Literature DB >> 28943955

p53 inhibits the upregulation of sirtuin 1 expression induced by c-Myc.

Fang Yuan1, Lu Liu2, Yonghong Lei3, Peifu Tang4.   

Abstract

Sirtuin 1 (Sirt1), a conserved NAD+ dependent deacetylase, is a mediator of life span by calorie restriction. However, Sirt1 may paradoxically increase the risk of cancer. Accordingly, the expression level of Sirt1 is selectively elevated in numerous types of cancer cell; however, the mechanisms underlying the differential regulation remain largely unknown. The present study demonstrated that oncoprotein c-Myc was a direct regulator of Sirt1, which accounts for the upregulation of Sirt1 expression only in the cells without functional p53. In p53 deficient cells, the overexpression of c-Myc increased Sirt1 mRNA and protein expression levels as well as its promoter activity, whereas the inhibitor of c-Myc, 10058-F4, induced decreased Sirt1 basal mRNA and protein expression levels. Deletion/mutation mapping analyses revealed that c-Myc bound to the conserved E-box[-189 to -183 base pair (bp)] of the Sirt1 promoter. In addition, p53 and c-Myc shared at least response element and the presence of p53 may block the binding of c-Myc to the Sirt1 promoter, thus inhibit the c-Myc mediated upregulation of Sirt1 promoter activity. The present study indicated that the expression level of Sirt1 was tightly regulated by oncoprotein c-Myc and tumor suppressor p53, which aids an improved understanding of its expression regulation and tumor promoter role in certain conditions.

Entities:  

Keywords:  c-Myc; p53; sirtuin 1; tumorigenesis

Year:  2017        PMID: 28943955      PMCID: PMC5594252          DOI: 10.3892/ol.2017.6661

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  27 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

Authors:  Wen Yong Chen; David H Wang; Raywhay Chiu Yen; Jianyuan Luo; Wei Gu; Stephen B Baylin
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

3.  Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.

Authors:  Beibei Mao; Guowei Zhao; Xiang Lv; Hou-Zao Chen; Zheng Xue; Ben Yang; De-Pei Liu; Chih-Chuan Liang
Journal:  Int J Biochem Cell Biol       Date:  2011-07-22       Impact factor: 5.085

4.  p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study.

Authors:  Yi Xie; Mohmad Ajaz Bulbul; Lingyun Ji; Casey M Inouye; Susan G Groshen; Anil Tulpule; Dennis P O'Malley; Endi Wang; Imran N Siddiqi
Journal:  Am J Clin Pathol       Date:  2014-04       Impact factor: 2.493

5.  p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Authors:  Jenny S L Ho; Weili Ma; Daniel Y L Mao; Samuel Benchimol
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway.

Authors:  Van B T Ta; Marjolein J W de Bruijn; Petra J ter Brugge; Jan Piet van Hamburg; Hans J A Diepstraten; Pieter Fokko van Loo; Rogier Kersseboom; Rudi W Hendriks
Journal:  Blood       Date:  2009-12-14       Impact factor: 22.113

7.  p53 acetylation is crucial for its transcription-independent proapoptotic functions.

Authors:  Hirohito Yamaguchi; Nicholas T Woods; Landon G Piluso; Heng-Huan Lee; Jiandong Chen; Kapil N Bhalla; Alvaro Monteiro; Xuan Liu; Mien-Chie Hung; Hong-Gang Wang
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

8.  SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma.

Authors:  Kyu Yun Jang; Sung Ho Hwang; Keun Sang Kwon; Kyung Ryoul Kim; Ha Na Choi; Na-Ri Lee; Jae-Yong Kwak; Byung-Hyun Park; Ho Sung Park; Myoung Ja Chung; Myoung Jae Kang; Dong Geun Lee; Hun Soo Kim; Hyeok Shim; Woo Sung Moon
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

9.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

10.  SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells.

Authors:  Ling Li; Tereza Osdal; Yinwei Ho; Sookhee Chun; Tinisha McDonald; Puneet Agarwal; Allen Lin; Su Chu; Jing Qi; Liang Li; Yao-Te Hsieh; Cedric Dos Santos; Hongfeng Yuan; Trung-Quang Ha; Mihaela Popa; Randi Hovland; Øystein Bruserud; Bjørn Tore Gjertsen; Ya-Huei Kuo; Wenyong Chen; Sonia Lain; Emmet McCormack; Ravi Bhatia
Journal:  Cell Stem Cell       Date:  2014-10-02       Impact factor: 24.633

View more
  2 in total

1.  A New Regulatory Mechanism Between P53 And YAP Crosstalk By SIRT1 Mediated Deacetylation To Regulate Cell Cycle And Apoptosis In A549 Cell Lines.

Authors:  Fang Yuan; Jinliang Wang; Ruixin Li; Xiao Zhao; Yuxuan Zhang; Biao Liu; Yonghong Lei; Yi Hu
Journal:  Cancer Manag Res       Date:  2019-09-23       Impact factor: 3.989

2.  Control of tissue homeostasis, tumorigenesis, and degeneration by coupled bidirectional bistable switches.

Authors:  Diego Barra Avila; Juan R Melendez-Alvarez; Xiao-Jun Tian
Journal:  PLoS Comput Biol       Date:  2021-11-19       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.